What we're reading, October 11, 2016: USPSTF recommendations maybe shouldn't be tied to insurance coverage; growing dispute over homeopathy research; and the harm of pharmaceutical companies' copay assistant programs.
Task force recommendations for preventive services shouldn’t be tied to insurance coverage, experts are arguing. According to NPR, with the implementation of the Affordable Care Act, recommendations from the United States Preventive Services Task Force are tied to insurance coverage as insurers have to cover the costs. However, former members of the task force believe the system in place leaves it vulnerable to lobbying that can corrupt the process. For example, Mylan has been lobbying to have the EpiPen deemed a preventive service, which would make price increases invisible to patients, but not to insurers.
When has something been studied long enough? Two researchers are disagreeing about whether homeopathy, a controversial arm of complementary medicine, should continue to be studied despite studies already showing it doesn’t work, according to STAT. The part of the National Institutes of Health charged with researching alternative medicine is also skeptical about homeopathy. However, Americans spent $3 billion on homeopathic remedies in 2007 and the FDA allows them to be sold without requiring proof the products can meet their claims. Now critics are saying regulatory agencies should go further.
Pharmaceutical companies’ copay assistance programs for expensive drugs may seem helpful, but Peter A. Ubel, MD, and Peter B. Bach, MD, wrote about the consequences in an article in the Annals of Internal Medicine. Unfortunately, copay assistance programs reduce public outcry over price hikes because they diminish price pressures. Plus, as an artificial price support, patients have less incentive to act consumer savvy. One solution to the problem could be requiring that pharmaceutical companies offer copay assistance to all patients and for all products.
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen